Hypoglycaemic constituents of Stachytarpheta cayennensis leaf

Planta Medica

Volumn 73, Issue 3, 2007, Pages 241-250

  Adebajo, Adeleke Clement ^a   Olawode, E O ^a   Omobuwajo, O R ^a   Adesanya, S A ^a   Begrow, F ^b   Elkhawad, A ^b   Akanmu, M A ^c   Edrada, R ^d   Proksch, P ^d   Schmidt, T J ^e   Klaes, M ^e   Verspohl, E J ^b  

^a OBAFEMI AWOLOWO UNIVERSITY   (Nigeria)

^b Institute of Clinical Chemistry   (Germany)

^c Faculty of Pharmacy   (Nigeria)

^d Institute of Pharmaceutical Biology   (Germany)

^e Institute of Pharmaceutical Biology and Phytochemistry   (Germany)

Author keywords

Alloxan diabetic rats; Diabetes mellitus; Hyperglycaemic rats; Hypoglycaemic activity; INS 1 cells; Stachytarpheta cayennensis; Verbenaceae

Indexed keywords

ACETIC ACID ETHYL ESTER; BUTANOL; GLIBENCLAMIDE; PLANT EXTRACT; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ACTIVITY; DRUG EFFECT; DRUG FORMULATION; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPOGLYCEMIA; IN VITRO STUDY; IN VIVO STUDY; INSULIN RELEASE; MALE; NIGERIA; NONHUMAN; PERU; PLANT LEAF; RAT; STACHYTARPHETA CAYENNENSIS; VERBENACEAE;

ADMINISTRATION, ORAL; ALLOXAN; ANIMALS; BLOOD GLUCOSE; CELL LINE, TUMOR; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSE; HYPOGLYCEMIC AGENTS; INSULIN; MALE; PHYTOTHERAPY; PLANT EXTRACTS; PLANT LEAVES; RATS; RATS, WISTAR; VERBENACEAE;

RATTUS; STACHYTARPHETA CAYENNENSIS; VERBENACEAE;

EID: 34250314124     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-967125     Document Type: Article

References (29)

1. Fajan SS. What is diabetes, definition, diagnosis and causes. Med Clin J N Am 1971; 55: 793-5.
2. Momo CEN, Oben JE, Tazoo D, Dongo E. Antidiabetic and hypolipidemic effects of Laportea ovalifolia (Urticaceae) in alloxan induced diabetic rats. Afr J Trad CAM 2006; 3: 36-43.
3. Ivorra MD, Payá M, Villar A. A review of natural products and plants as potential antidiabetic drugs. J Ethnopharmacol 1989; 27: 243-75.
4. Prince SPM, Menon VP, Pari L. Hypoglycaemic activity of Syzygium cumini seed: effect on lipid peroxidation in alloxan-diabetic rats. J Ethnopharmacol 1998; 61: 1-7.
5. Roman-Ramos R, Flores-Saenz JL, Alarcon-Aquilar FJ. Anti-hyperglycaemic effect of some edible plants. J Ethnopharmacol 1995; 48: 25-32.
6. Verspohl EJ. Recommended testing in diabetes research. Planta Med 2002; 68: 581-90.
7. Ahmad M, Akhtar MS, Malik T, Gilani AH. Hypoglycaemic action of the flavonoid fraction of Cuminum nigrum seeds. Phytother Res 2000; 14: 103-6.
8. Haselwood EL, Motter GG. Handbook of Hawaiian weeds. Hawaii: University of Hawaii Press, Honolulu; 1966: 334
9. Balik MJ. Notes on some medicinal and poisonous plants of Amazonian Peru. Adv Econ Bot 1985; 1: 1-8.
10. Akanmu MA, Olayiwola G, Ukpomwan OE, Honda K. Acute toxicity and sleep-wake EEG analysis of Stachytarpheta cayennensis (Verbenaceae) in rodents. Afr J Trad CAM 2005; 2: 222-32
11. Schapoval EES, Winter de Vargas MR, Chaves CG, Bridi R, Zuanazzi JA, Henriques AT. Anti-inflammatory and antinociceptive activities of extracts and isolated compounds from Stachytarpheta cayennensis. J Ethnopharmacol 1998; 60: 53-9
12. Vela SM, Souccar C, Lima-Landman MT, Lapa AJ. Inhibition of gastric acid secretion by the aqueous extract and purified extract of Stachytarpheta cayennensis. Planta Med 1997; 63: 36-9
13. Robinson RD, Williams LA, Lindo JF, Terry SI, Mansingh A. Inactivation of Strongyloides stercoralis filariform larvae in vitro by six Jamaican plant extracts and three commercial anthelmintics. W Ind Med J 1990; 39: 213-7.
14. Schmeda-Hirshmann G, Rojas de Arias A. A screening method for natural products on Triatomine bugs. Phytother Res 1992; 62: 68-73.
15. Duke JA, Vazquez Martrinez R. Amazonian Ethnobotanical Dictionary (Peru). Boca Raton: CRC Press; 1994: 210-5
16. Lin SR, Chen AH. Phytochemical study on Stachytarpheta jamaicensis. Chung-Kuo Nung Yen Hua Hsuehib Hui Chih 1976; 15: 151-3
17. Taoubi K, Fauvel MT, Glieye J, Rouraste I. Caffeic and heteroside esters from Verbenaceae. Polyphenols 1992; 16: 174-7.
18. Damtoft S, Jensen SR, Nielsen BJ. The identity of the iridoid glucoside tarphetalin with Ipolamide. Phytochemistry 1984; 23: 907-8.
19. De Costa AO. Pharmacognosy of Stachytarpheta jamaicensis. Rev Bras Farmacol 1960; 41: 135-6.
20. Saha JC, Savini EC, Kasinathan S. Ecbolic properties of Indian medicinal plants, Part 1. Ind J Med Res 1961; 49: 130-51.
21. Melita RS, Castro O. Pharmacological and chemical evaluation of Stachytarpheta cayennensis. Rev Biol Trop 1996; 44: 353-9.
22. Bozdag O, Verspohl EJ, Ertan R. Synthesis and hypoglycaemic activity of some new flavones derivatives 11(4′-Flavonyl-2,4-thiazolidinediones). Arzneimittelforschung/Drug Res 2000; 50: 539-43.
23. Verspohl EJ, Bauer K, Neddermann E. Antidiabetic effect of Cinnamomum cassia and Cinnamomum zeylanicum in vivo and in vitro. Phytother Res 2005; 19: 203-6.
24. Goldner M, Gomori G. Alloxan-induced diabetes. Endocrinology 1943; 33: 297-9.
25. Defronzo RA. Pharmacological therapy for type II diabetes mellitus. Ann Intern Med 1999; 131: 281-303.
26. Gilman AG, Rall TW, Nies AS, Tayer P. Goodman and Gilman's: Pharmacological basis of therapeutics, 8th edition. New York: Pergamon Press; 1990: 1317-22, 1463-95.
27. De Luca C, Guiso M, Martino C. 6β-Hydroxyipolamide, an iridoid glucoside from Stachytarpheta mutabilis. Phytochemistry 1983; 22: 1185-7.
28. Kanchanapooma T, Kasaia R, Yamasakia K. Phenolic glycosides from Barnettia kerrii. Phytochemistry 2002; 59: 565-70.
29. Miyase T, Koizumi A, Ueno A, Noro T, Kuroyanagi M, Fukushima S et al. Studies on the acyl glycosides from Leucoseptrum japonicum. Chem Pharm Bull 1982; 30: 2732-7.